Identifying key signaling pathways and regulatory molecules, such as PIAS3, PIP, STAT5, and SOCS3 in breast cancer (BC) cells, can provide valuable insights into the mechanisms of the disease and potentially lead to the development of targeted therapies. This evidence concerns the gene STAT5A and breast carcinoma.